Clinical Trial: Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841470) titled 'Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia' on Sept. 19.

Brief Summary: This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

Study Start Date: Oct. 01, 2025

Study Type: INTERVENTIONAL

Condition: Keratoconus Corneal Ectasia

Intervention: COMBINATION_PRODUCT: Riboflavin 0.1% ophthalmic solution and pulsed light

Use of riboflavin 0.1% eye drops and pulsed 18 milliwatt/cm2 ultraviolet A light for 10 minutes

COMBINATION_PRODUCT: Riboflavin 0.1% ophthalmic solution and non-pulsed light

Use of riboflavin 0.1% eye drops and non-pu...